Unknown

Dataset Information

0

Polo-like kinase inhibition as a therapeutic target in acute myeloid leukemia.

ABSTRACT:

SUBMITTER: Bewersdorf JP 

PROVIDER: S-EPMC8238245 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Targeting polo-like kinase 1 in acute myeloid leukemia.
| S-EPMC4365055 | biostudies-literature
Unknown miR-10a as a therapeutic target and predictive biomarker for MDM2 inhibition in acute myeloid leukemia.
| S-EPMC8257503 | biostudies-literature
Unknown Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemia.
| S-EPMC7484148 | biostudies-literature
Unknown CD157: From Myeloid Cell Differentiation Marker to Therapeutic Target in Acute Myeloid Leukemia.
| S-EPMC6952987 | biostudies-literature
Unknown Chemical Inhibition of Salt-Inducible Kinase as Therapeutic Strategy in Acute Myeloid Leukemia
2019-11-01 | GSE129863 | GEO
Unknown SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia.
| S-EPMC8410582 | biostudies-literature
Unknown Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes.
| S-EPMC6558520 | biostudies-literature
Unknown Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia.
| S-EPMC3978274 | biostudies-literature
Unknown T-LAK cell-originated protein kinase presents a novel therapeutic target in FLT3-ITD mutated acute myeloid leukemia.
| S-EPMC4741775 | biostudies-literature
Unknown Salt-inducible kinase inhibition suppresses acute myeloid leukemia progression in vivo.
| S-EPMC6940199 | biostudies-literature